Category: Generic medications

The U.S. Food and Drug Administration (FDA) first approved generic versions of cinacalcet on March 8, 2018. This milestone introduced competition for the brand-name drug Sensipar, which had sales of $1.72 billion in 2017. The question of *when did cinacalcet go generic?* is pivotal for understanding patient access and cost.

While several drug manufacturers received FDA approval for generic forms of MyDayis in 2022 and 2023, the brand is protected by active patents [1.2.4, 1.4.5, 1.4.8]. The answer to 'When did MyDayis go generic?' is complex; while technically available, a broad launch is tied to patent expirations.

As one of the top 10 generic pharmaceutical companies in the world, Aurobindo Pharma plays a significant role in global healthcare [1.6.2]. But a common point of confusion is what is the drug Aurobindo used for? The answer is that Aurobindo is a manufacturer, not a single drug.